Hypera S.A. (HYPMY)
USD 2.65
(1.92%)
USD 2.65
(1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.09 Billion | 2.03 Billion | 1.39 Billion | 1.18 Billion | 823.88 Million | 1.06 Billion |
| Net Income | 1.64 Billion | 1.59 Billion | 1.2 Billion | 1.2 Billion | 1.06 Billion | 1.22 Billion |
| Depreciation & Amortization | 230.27 Million | 169.1 Million | 133.68 Million | 121.48 Million | 120.37 Million | 88.93 Million |
| Deferred income taxes | -365.69 Million | - | 460.11 Million | -48.16 Million | 86.79 Million | 32 Million |
| Stock-based compensation | 46.19 Million | 24.87 Million | 24.95 Million | 19.19 Million | 24.4 Million | 19.09 Million |
| Change in working capital | -467.65 Million | -726.52 Million | -743.87 Million | -212.14 Million | -450.37 Million | -290.85 Million |
| Other non-cash items | 1.38 Million | 973.51 Million | 314.92 Million | 96.72 Million | -19.93 Million | -7.54 Million |
| Investing Cash Flow | -794.66 Million | -1.74 Billion | -4.41 Billion | -1.89 Billion | -306.52 Million | -170.52 Million |
| Investments in PPE | -814.77 Million | -1.5 Billion | -838.88 Million | -1.92 Billion | -361.62 Million | -220.85 Million |
| Acquisitions | -125.99 Million | -226.94 Million | -3.67 Billion | -45.94 Million | -1 Million | -270 Thousand |
| Investment purchases | - | -148.62 Million | -138.86 Million | -1.4 Billion | - | - |
| Sales/Maturities of investments | - | - | 101.26 Million | 4.89 Million | - | - |
| Other Investing Activities | 146.1 Million | 142.68 Million | 139.59 Million | 1.47 Billion | 56.09 Million | 50.6 Million |
| Financing Cash Flow | -579.93 Million | 278.95 Million | 557.05 Million | 3.2 Billion | 82.21 Million | -771.23 Million |
| Debt repayment | -228.91 Million | -464.72 Million | -519.68 Million | -98.97 Million | -123.39 Million | -328.74 Million |
| Dividends payments | -759.88 Million | -806.2 Million | -745.93 Million | -682.47 Million | -623.42 Million | -632.99 Million |
| Common Stock Repurchased | -88.45 Million | -87 Million | -128.66 Million | - | -72.18 Million | -4.28 Million |
| Common Stock Issuance | 39.48 Million | 84.3 Million | 18.69 Million | 41.41 Million | 24.33 Million | 7.41 Million |
| Other Financing Activities | 457.83 Million | 1.55 Billion | 1.93 Billion | 3.94 Billion | 876.88 Million | 183.08 Million |
| Accounts receivables | 243 Million | -262.82 Million | -514.86 Million | -384.74 Million | -397.88 Million | -39.56 Million |
| Accounts payables | -10.98 Million | 91.67 Million | 28.88 Million | -49.03 Million | 144.66 Million | 12.47 Million |
| Inventory | -90.97 Million | -961.65 Million | -405.53 Million | -329.24 Million | -127.46 Million | -192.56 Million |
| Other working capital | -608.7 Million | 406.28 Million | 147.64 Million | 550.88 Million | -69.68 Million | -98.29 Million |
| Cash at beginning of period | 2.86 Billion | 2.28 Billion | 4.74 Billion | 2.24 Billion | 1.64 Billion | 1.52 Billion |
| Cash at end of period | 2.58 Billion | 2.86 Billion | 2.28 Billion | 4.74 Billion | 2.24 Billion | 1.64 Billion |
| Capital Expenditure | -814.77 Million | -1.5 Billion | -838.88 Million | -1.92 Billion | -361.62 Million | -220.85 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -281.58 Million | 575.41 Million | -2.45 Billion | 2.49 Billion | 599.56 Million | 124.73 Million |
| Free Cash Flow | 278.24 Million | 529.33 Million | 560.24 Million | -744.16 Million | 462.25 Million | 845.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 492.13 Million | 394.87 Million | 1.64 Billion | 306.77 Million | 472.12 Million | 471.11 Million |
| Depreciation & Amortization | 67.93 Million | 68.32 Million | 230.27 Million | 61.89 Million | 61.33 Million | 56.53 Million |
| Deferred income taxes | - | - | -365.69 Million | 278.2 Million | -67.93 Million | 66.78 Million |
| Stock-based compensation | 8.83 Million | 5.9 Million | 46.19 Million | 16.67 Million | 11.92 Million | 11.07 Million |
| Change in working capital | -24.2 Million | -203.7 Million | -467.65 Million | 112.52 Million | -9.37 Million | -279.69 Million |
| Other non-cash items | 13.5 Million | 93.47 Million | 1.38 Million | -359.45 Million | 256.3 Million | 252.27 Million |
| Investing Cash Flow | -121.63 Million | -105.5 Million | -794.66 Million | -183.17 Million | -237.54 Million | -203.32 Million |
| Investments in PPE | -160.47 Million | -160.42 Million | -814.77 Million | -213.58 Million | -182.05 Million | -214.61 Million |
| Acquisitions | -4.77 Million | 38.99 Thousand | -125.99 Million | -8.46 Million | -94.51 Million | -18.6 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 43.61 Million | 54.88 Million | 146.1 Million | 38.86 Million | 39.03 Million | 29.89 Million |
| Financing Cash Flow | -430.81 Million | 466.59 Million | -579.93 Million | 129.03 Million | -407.91 Million | 677.34 Million |
| Debt repayment | -370.15 Million | -528.22 Million | -228.91 Million | -150.44 Million | -133.02 Million | -48 Million |
| Dividends payments | -25.76 Million | -53.97 Million | -759.88 Million | -27.83 Million | -27.51 Million | -27.03 Million |
| Common Stock Repurchased | -35.12 Million | -20.68 Million | -88.45 Million | - | - | -44.02 Million |
| Common Stock Issuance | 222 Thousand | 13.02 Million | 39.48 Million | 6.42 Million | 1000.00 | 6.95 Million |
| Other Financing Activities | -385.68 Million | -257.52 Million | 457.83 Million | 300.89 Million | -247.38 Million | 789.45 Million |
| Accounts receivables | -296.39 Million | -36.69 Million | 243 Million | 340.46 Million | 46.21 Million | -214.44 Million |
| Accounts payables | -17.33 Million | -21.26 Million | -10.98 Million | 82.56 Million | -84.74 Million | -21.73 Million |
| Inventory | 114.36 Million | 74.1 Million | -90.97 Million | -4.34 Million | 89.41 Million | 54.45 Million |
| Other working capital | 175.16 Million | -219.84 Million | -608.7 Million | -306.16 Million | -60.24 Million | -97.96 Million |
| Cash at beginning of period | 3.17 Billion | 2.58 Billion | 2.86 Billion | 2.21 Billion | 2.13 Billion | 1.08 Billion |
| Cash at end of period | 2.83 Billion | 3.17 Billion | 2.58 Billion | 2.58 Billion | 2.21 Billion | 2.13 Billion |
| Capital Expenditure | -160.47 Million | -160.42 Million | -814.77 Million | -213.58 Million | -182.05 Million | -214.61 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -338.32 Million | 593.55 Million | -281.58 Million | 362.49 Million | 78.91 Million | 1.05 Billion |
| Free Cash Flow | 53.65 Million | 72.03 Million | 278.24 Million | 203.04 Million | 542.31 Million | 363.47 Million |
0697
032640
ETTE
BALPHARMA
DII-B
PDS